These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 21660133)
41. The effect of Epstein-Barr virus Latent Membrane Protein 2 expression on the kinetics of early B cell infection. Wasil LR; Tomaszewski MJ; Hoji A; Rowe DT PLoS One; 2013; 8(1):e54010. PubMed ID: 23308294 [TBL] [Abstract][Full Text] [Related]
42. Epstein-Barr Virus (EBV) Latent Protein EBNA3A Directly Targets and Silences the Bazot Q; Paschos K; Allday MJ J Virol; 2018 Apr; 92(7):. PubMed ID: 29367247 [TBL] [Abstract][Full Text] [Related]
43. Transformation of rabbit lymphocytes by an Epstein-Barr virus-related herpesvirus from Macaca arctoides. Meerbach A; Friedrichs C; Thust R; Wutzler P Arch Virol; 2004 Jun; 149(6):1083-94. PubMed ID: 15168196 [TBL] [Abstract][Full Text] [Related]
44. Transformed SV3T3 cells have a reduced lysosomal compartment and lower levels of enzyme activity than 3T3 cells. Kundra V; Dean MF Exp Cell Res; 1990 Jul; 189(1):93-9. PubMed ID: 1693341 [TBL] [Abstract][Full Text] [Related]
46. Epstein-Barr virus induces an oxidative stress during the early stages of infection in B lymphocytes, epithelial, and lymphoblastoid cell lines. Lassoued S; Ben Ameur R; Ayadi W; Gargouri B; Ben Mansour R; Attia H Mol Cell Biochem; 2008 Jun; 313(1-2):179-86. PubMed ID: 18414998 [TBL] [Abstract][Full Text] [Related]
47. Propagation of EBV-driven Lymphomatous Transformation of Peripheral Blood B Cells by Immunomodulators and Biologics Used in the Treatment of Inflammatory Bowel Disease. Levhar N; Ungar B; Kopylov U; Fudim E; Yavzori M; Picard O; Amariglio N; Chowers Y; Shemer-Avni Y; Mao R; Chen MH; Ye Z; Eliakim R; Ben-Horin S Inflamm Bowel Dis; 2020 Aug; 26(9):1330-1339. PubMed ID: 32322878 [TBL] [Abstract][Full Text] [Related]
48. Epstein-Barr Virus Episome Physically Interacts with Active Regions of the Host Genome in Lymphoblastoid Cells. Wang L; Laing J; Yan B; Zhou H; Ke L; Wang C; Narita Y; Zhang Z; Olson MR; Afzali B; Zhao B; Kazemian M J Virol; 2020 Nov; 94(24):. PubMed ID: 32999023 [TBL] [Abstract][Full Text] [Related]
49. Heterogeneity of EBV-transformable human B lymphocyte populations. Chan MA; Stein LD; Dosch HM; Sigal NH J Immunol; 1986 Jan; 136(1):106-12. PubMed ID: 2999241 [TBL] [Abstract][Full Text] [Related]
50. Expression of glycosidase activities during germination of Dictyostelium discoideum spores. Tisa LS; Cotter DA J Bacteriol; 1980 Feb; 141(2):436-42. PubMed ID: 6767680 [TBL] [Abstract][Full Text] [Related]
51. Characteristics and responses of EBV immortalized B cells from periodontal disease patients. Celenligil H; Ebersole JL Oral Dis; 1997 Dec; 3(4):262-71. PubMed ID: 9643223 [TBL] [Abstract][Full Text] [Related]
53. An Epstein-Barr virus that expresses only the first 231 LMP1 amino acids efficiently initiates primary B-lymphocyte growth transformation. Kaye KM; Izumi KM; Li H; Johannsen E; Davidson D; Longnecker R; Kieff E J Virol; 1999 Dec; 73(12):10525-30. PubMed ID: 10559372 [TBL] [Abstract][Full Text] [Related]
54. EBV Immortalization of human B lymphocytes separated from small volumes of cryo-preserved whole blood. Amoli MM; Carthy D; Platt H; Ollier WE Int J Epidemiol; 2008 Apr; 37 Suppl 1():i41-5. PubMed ID: 18381392 [TBL] [Abstract][Full Text] [Related]
55. Infection of leukaemic B lymphocytes by Epstein Barr virus. Doyle MG; Catovsky D; Crawford DH Leukemia; 1993 Nov; 7(11):1858-64. PubMed ID: 8231253 [TBL] [Abstract][Full Text] [Related]
56. Lysosomal enzyme replacement using alpha 2-macroglobulin as a transport vehicle. Tsuji A; Oda R; Sakiyama K; Nagamune H; Itoh K; Kase R; Sakuraba H; Suzuki Y; Matsuda Y J Biochem; 1994 May; 115(5):937-44. PubMed ID: 7525546 [TBL] [Abstract][Full Text] [Related]
57. Epstein-Barr virus-carrying B cells in the blood during acute infectious mononucleosis give rise to lymphoblastoid lines in vitro by release of transforming virus and by proliferation. Lewin N; Aman P; Akerlund B; Gustavsson E; Carenfelt C; Lejdeborn L; Klein G; Klein E Immunol Lett; 1990 Oct; 26(1):59-65. PubMed ID: 2177451 [TBL] [Abstract][Full Text] [Related]
58. Epstein-Barr Virus (EBV): infection, propagation, quantitation, and storage. Lan K; Verma SC; Murakami M; Bajaj B; Robertson ES Curr Protoc Microbiol; 2007 Aug; Chapter 14():Unit 14E.2. PubMed ID: 18770612 [TBL] [Abstract][Full Text] [Related]
59. Epstein-Barr virus (EBV) receptors, complement receptors, and EBV infectibility of different lymphocyte fractions of human peripheral blood. II. Epstein-Barr virus studies. Einhorn L; Steinitz M; Yefenof E; Ernberg I; Bakacs T; Klein G Cell Immunol; 1978 Jan; 35(1):43-58. PubMed ID: 202404 [No Abstract] [Full Text] [Related]
60. Induction of latent membrane protein expression in in vitro Epstein-Barr virus-infected leukaemic B lymphocytes by interleukin 4 and antibodies to CD40. Crawford DH; Thomas JA; Gregory CD; Catovsky D; Chaggar K Leukemia; 1995 May; 9(5):747-53. PubMed ID: 7539512 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]